[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334073-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334073-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-biological-function-of-extracellular-vesicles-in-prostate-cancer-and-their-clinical-application-as-diagnostic-and-prognostic-biomarkers","The biological function of extracellular vesicles in prostate cancer and their clinical application - as diagnostic and prognostic biomarkers","","Prostate cancer is among the most commonly diagnosed malignancies and a leading cause of cancer-related death worldwide, and its high heterogeneity—from indolent to metastatic disease—demands accurate patient stratification. Extracellular vesicles (EVs) are membrane-coated particles carrying specific cargo of nucleic acids, proteins, and metabolites. This review outlines EVs’ biological roles in prostate cancer, emphasizing interactions with the tumor microenvironment, horizontal transfer of metastatic traits and drug resistance, and their emerging clinical value as diagnostic and prognostic biomarkers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-biological-function-of-extracellular-vesicles-in-prostate-cancer-and-their-clinical-application-as-diagnostic-and-prognostic-biomarkers/334073/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-biological-function-of-extracellular-vesicles-in-prostate-cancer-and-their-clinical-application-as-diagnostic-and-prognostic-biomarkers/334073.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are new diagnostic and prognostic biomarkers needed in prostate cancer?","Question",{"text":63,"@type":64},"Prostate cancer shows high heterogeneity and includes forms ranging from slow-growing tumors to metastatic disease. Therapy selection and outcomes depend on proper patient stratification, and drug insensitivity such as castration resistance can lead to relapse and poor prognosis, creating a need for improved biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are extracellular vesicles (EVs) and what cargo do they carry?",{"text":68,"@type":64},"EVs are membrane-coated particles that enclose biological cargo including nucleic acids (such as mRNAs and miRNAs/other non-coding RNAs), DNA, proteins, and lipids. They are released by cells into the extracellular space and participate in cell-to-cell communication.",{"name":70,"@type":61,"acceptedAnswer":71},"How do EVs contribute to prostate cancer progression and drug resistance?",{"text":72,"@type":64},"EVs can deliver cargo to neighboring cells to create a tumor-sustaining microenvironment. EVs derived from the tumor microenvironment are taken up by prostate cancer cells, supporting proliferative and invasive needs and contributing to resistance against anticancer drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334073,1791123461,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer and Metastasis Reviews (2024) 43:1611–1627 [https://doi.org/10.1007/s10555-024-10210-w](https://doi.org/10.1007/s10555-024-10210-w)  \nThe biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers  \nPatrizia Limonta1 · Sara Marchesi1 · Gaia Giannitti1 · Lavinia Casati2 · Fabrizio Fontana1  \nReceived: 29 February 2024 / Accepted: 5 September 2024 / Published online: 24 September 2024 © The Author(s) 2024  \nAbstract  \nProstate cancer (PCa) is one of the most commonly diagnosed malignancies and main causes of cancer-related deaths worldwide. It is characterized by high heterogeneity, ranging from slow-growing tumor to metastatic disease. Since both therapy selection and outcome strongly rely on appropriate patient stratification, it is crucial to differentiate benign from more aggressive conditions using new and improved diagnostic and prognostic biomarkers. Extracellular vesicles (EVs) are membrane-coated particles carrying a specific biological cargo composed of nucleic acids, proteins, and metabolites. Here, we provide an overview of the role of EVs in PCa, focusing on both their biological function and clinical value. Specifically, we summarize the oncogenic role of EVs in mediating the interactions with PCa microenvironment as well as the horizontal transfer of metastatic traits and drug resistance between PCa cells. Furthermore, we discuss the potential usage of EVs as innovative tools for PCa diagnosis and prognosis.  \nKeywords Prostate cancer · Extracellular vesicles · Tumor microenvironment · Drug resistance · Diagnosis · Prognosis  \n1 Introduction  \nProstate cancer (PCa) is the second most commonly diagnosed malignancy and the fifth leading cause of cancerrelated deaths among men worldwide [1] . Although most PCa patients are diagnosed with inert or slow-growing disease, it has been estimated that approximately 20% of men have a high-risk and potentially lethal tumor. Furthermore, PCa is characterized by high heterogeneity and can be subdivided into various clinical states that are treated with different therapeutic strategies. Indeed, active surveillance is generally preferred for patients with indolent disease, radiotherapy and partial/radical surgery are adopted for individuals with localized tumor, while aggressive cancers are usually managed with a combination of hormonal therapy (GnRH agonists/antagonists, androgen receptor antagonists, and androgen synthesis inhibitors) and chemotherapy  \n* Fabrizio Fontana [fabrizio.fontana@unimi.it](fabrizio.fontana@unimi.it)  \n1 Department of Pharmacological and Biomolecular Sciences“Rodolfo Paoletti”, Università Degli Studi Di Milano, Milan, Italy  \n2 Department of Health Sciences, Università Degli Studi Di Milano, Milan, Italy  \n(taxanes) [2, 3]. However, patients frequently develop drug insensitivity, especially castration resistance, resulting in poor therapeutic outcome, disease relapse, and dismal prognosis [4, 5] . In this context, there is an urgent need to find novel clinically valuable prognostic and diagnostic biomarkers for PCa, in order to predict and prevent tumor recurrence and therapy evasion.  \nExtracellular vesicles (EVs) are a family of lipid bilayerencapsulated particles enclosing a cargo of different bioactive molecules, including mRNAs, miRNAs, and other non-coding RNAs (ncRNAs), DNA, proteins, and lipids. EVs are shed by cells into the extracellular space and are deeply involved in the cell-to-cell communication occurring in different biological and pathological processes [6] . Based on their size, biogenesis, mechanism of release, and molecular cargo, they are classified in small and large vesicles (sEVs and lEVs, also known as exosomes and microvesicles, respectively) . However, according to the recommendations of the International Society for Extracellular Vesicles (ISEV), the term “EVs” is now generally used to refer to both these vesicular families [7] . In the last ","cbCaitjSVp9kYuFN","https://ap.wps.com/l/cbCaitjSVp9kYuFN","pdf",1269512,17,"English","# Abstract\n# Introduction\n# Biological roles of EVs in the cell-to-cell communication within PCa microenvironment","[{\"question\":\"Why are new diagnostic and prognostic biomarkers needed in prostate cancer?\",\"answer\":\"Prostate cancer shows high heterogeneity and includes forms ranging from slow-growing tumors to metastatic disease. Therapy selection and outcomes depend on proper patient stratification, and drug insensitivity such as castration resistance can lead to relapse and poor prognosis, creating a need for improved biomarkers.\"},{\"question\":\"What are extracellular vesicles (EVs) and what cargo do they carry?\",\"answer\":\"EVs are membrane-coated particles that enclose biological cargo including nucleic acids (such as mRNAs and miRNAs/other non-coding RNAs), DNA, proteins, and lipids. They are released by cells into the extracellular space and participate in cell-to-cell communication.\"},{\"question\":\"How do EVs contribute to prostate cancer progression and drug resistance?\",\"answer\":\"EVs can deliver cargo to neighboring cells to create a tumor-sustaining microenvironment. EVs derived from the tumor microenvironment are taken up by prostate cancer cells, supporting proliferative and invasive needs and contributing to resistance against anticancer drugs.\"}]","The biological function of extracellular vesicles in prostate cancer and their clinical application - as diagnostic and prognostic biomarkers | PDF",1790005199,43]